Featured Research

from universities, journals, and other organizations

Intake Of Dietary Copper Helps Alzheimer's Patients

Date:
October 4, 2005
Source:
Case Western Reserve University
Summary:
As one of the services for patients with Alzheimer's disease, the Department of Psychiatry at the Saarland University Medical Center offers participation in a clinical phase II trial. This clinical trial aims to elucidate a potential beneficial effect of copper orotate (an organic copper salt), which is given together with a standard cholinesterase inhibitor. A diagnosis of mild to moderate dementia of the Alzheimer type is a prerequisite.

Treatmentstarts after all prerequisites to participate have been met. Half ofthe patients receive 8 mg copper orotate per day, the other half aplacebo. Both patients and psychiatrists are blinded. During the12-month long double-blind phase, there will be extensive laboratory,clinical and neuropsychological tests. After the double-blind phase, weoffer an open-label phase for all patients. At present, 15 patientshave finished the double-blind phase. The copper medication is welltolerated.

Alzheimer is characterized by the presence of amyloidplaques, which are composed primarily of Aß peptide. Aß is producedwithin neurons and is liberated from the larger amyloid ß proteinprecursor (AßPP). Lower levels of copper have been reported in thebrain of AßPP transgenic mice and post-mortem in AD patients. Thisconcept has been found to be true also in vitro by Professor Dr. GerdMulthaup (FU Berlin) in 1999. Two recent papers, which have beenpublished in PNAS in 2003 have proven a beneficial effect of elevatedcopper in transgenic AßPP mice. In the present study, the teams led byBayer and Multhaup have found that low copper level in blood correlateswith advanced memory deficits, as tested by the well establishedADAS-cog neuropsychological test battery. Patients with higher bloodcopper levels make fewer mistakes in this memory test. This resultsupports the notion of a mild copper deficiency in AD patients. Anincreased uptake of dietary copper may therefore be therapeuticallyrelevant.

###

The study has been published in the September2005 issue of the Journal of Alzheimer's Disease, Volume 8, Issue 1published by IOS Press: "Cognitive decline correlates with low plasmaconcentrations of copper in patients with mild to moderate Alzheimer'sdisease" (JAD, Vol. 8, Issue 1).



Story Source:

The above story is based on materials provided by Case Western Reserve University. Note: Materials may be edited for content and length.


Cite This Page:

Case Western Reserve University. "Intake Of Dietary Copper Helps Alzheimer's Patients." ScienceDaily. ScienceDaily, 4 October 2005. <www.sciencedaily.com/releases/2005/10/051004084327.htm>.
Case Western Reserve University. (2005, October 4). Intake Of Dietary Copper Helps Alzheimer's Patients. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2005/10/051004084327.htm
Case Western Reserve University. "Intake Of Dietary Copper Helps Alzheimer's Patients." ScienceDaily. www.sciencedaily.com/releases/2005/10/051004084327.htm (accessed October 21, 2014).

Share This



More Health & Medicine News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) — The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) — Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) — A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) — The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins